NO984344L - Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger - Google Patents
Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analogerInfo
- Publication number
- NO984344L NO984344L NO984344A NO984344A NO984344L NO 984344 L NO984344 L NO 984344L NO 984344 A NO984344 A NO 984344A NO 984344 A NO984344 A NO 984344A NO 984344 L NO984344 L NO 984344L
- Authority
- NO
- Norway
- Prior art keywords
- analogs
- propylpiperonyalamine
- alfa
- asymmetric synthesis
- new asymmetric
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/58—Radicals substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Det er beskrevet fremgangsmåter for fremstilling av R-a-propyl-piperonylamin og dets analoger, slike forbindleser er nyttige mellomprodukter ved fremstillingen av elastase inhibitorer, og mellomprodukter som er nyttige for fremstilling av R-a- propylpiperonylamin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1395596P | 1996-03-22 | 1996-03-22 | |
PCT/US1997/003466 WO1997034887A1 (en) | 1996-03-22 | 1997-03-17 | NOVEL ASYMMETRIC SYNTHESIS OF R-α-PROPYL-PIPERONYL AMINE AND ITS ANALOGS |
Publications (2)
Publication Number | Publication Date |
---|---|
NO984344L true NO984344L (no) | 1998-09-18 |
NO984344D0 NO984344D0 (no) | 1998-09-18 |
Family
ID=21762727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO984344A NO984344D0 (no) | 1996-03-22 | 1998-09-18 | Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger |
Country Status (23)
Country | Link |
---|---|
US (1) | US5932749A (no) |
EP (1) | EP0888329A1 (no) |
JP (1) | JP2000506891A (no) |
KR (1) | KR20000064735A (no) |
CN (1) | CN1218463A (no) |
AR (1) | AR006521A1 (no) |
AU (1) | AU719633B2 (no) |
BR (1) | BR9708233A (no) |
CA (1) | CA2249401A1 (no) |
CZ (1) | CZ295098A3 (no) |
EA (1) | EA001207B1 (no) |
EE (1) | EE9800299A (no) |
HR (1) | HRP970165A2 (no) |
IL (1) | IL126223A0 (no) |
LT (1) | LT4540B (no) |
LV (1) | LV12259B (no) |
NO (1) | NO984344D0 (no) |
NZ (1) | NZ331875A (no) |
PL (1) | PL329070A1 (no) |
SI (1) | SI9720023A (no) |
SK (1) | SK127398A3 (no) |
WO (1) | WO1997034887A1 (no) |
ZA (1) | ZA972342B (no) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU5587299A (en) | 1998-08-31 | 2000-03-21 | Du Pont Pharmaceuticals Company | An efficient process for the preparation of a human leukocyte elastase inhibitor |
DE60238218D1 (de) * | 2001-09-12 | 2010-12-16 | Anormed Inc | Synthese von enantiomerenreinen, aminosubstituierten kondensierten bicyclischen ringen |
AU2009333391B2 (en) * | 2008-12-15 | 2013-05-02 | Taigen Biotechnology Co., Ltd. | Stereoselective synthesis of piperidine derivatives |
AR090100A1 (es) | 2012-02-21 | 2014-10-22 | Celgene Corp | Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina |
US9126906B2 (en) | 2012-02-21 | 2015-09-08 | Celgene Corporation | Asymmetric synthetic processes for the preparation of aminosulfone compounds |
US11357742B2 (en) | 2015-12-14 | 2022-06-14 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
US10953003B2 (en) | 2015-12-14 | 2021-03-23 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
CN108883091A (zh) | 2015-12-22 | 2018-11-23 | X4 制药有限公司 | 用于治疗免疫缺陷病的方法 |
CA3019394A1 (en) | 2016-04-08 | 2017-10-12 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
ES2870920T3 (es) | 2016-06-21 | 2021-10-28 | X4 Pharmaceuticals Inc | Inhibidores de CXCR4 y usos de los mismos |
US11332470B2 (en) | 2016-06-21 | 2022-05-17 | X4 Pharmaceuticals, Inc. | CXCR4 inhibitors and uses thereof |
WO2017223229A1 (en) | 2016-06-21 | 2017-12-28 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
WO2023034510A1 (en) | 2021-09-01 | 2023-03-09 | ATAI Life Sciences AG | Synthesis of mdma or its optically active ( r)- or ( s)-mdma isomers |
US20230109467A1 (en) * | 2021-09-17 | 2023-04-06 | ATAI Life Sciences AG | Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric salts |
US11845736B2 (en) | 2021-10-01 | 2023-12-19 | Empathbio, Inc. | Prodrugs of MDMA, MDA, and derivatives thereof |
WO2023129958A2 (en) | 2021-12-28 | 2023-07-06 | ATAI Life Sciences AG | Nitric oxide releasing prodrugs of mda and mdma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3819438A1 (de) * | 1987-06-30 | 1989-01-19 | Basf Ag | Verfahren zur herstellung von optisch aktiven 1-arylethylaminen |
IL99658A0 (en) * | 1990-10-15 | 1992-08-18 | Merck & Co Inc | Substituted azetidinones and pharmaceutical compositions containing them |
US5149838A (en) * | 1991-09-20 | 1992-09-22 | Merck & Co., Inc. | Intermediates for substituted azetidinones useful as anti-inflammatory and antidegenerative agents |
-
1997
- 1997-03-17 IL IL12622397A patent/IL126223A0/xx unknown
- 1997-03-17 WO PCT/US1997/003466 patent/WO1997034887A1/en not_active Application Discontinuation
- 1997-03-17 JP JP9533500A patent/JP2000506891A/ja active Pending
- 1997-03-17 CA CA002249401A patent/CA2249401A1/en not_active Abandoned
- 1997-03-17 AU AU21968/97A patent/AU719633B2/en not_active Ceased
- 1997-03-17 NZ NZ331875A patent/NZ331875A/xx unknown
- 1997-03-17 PL PL97329070A patent/PL329070A1/xx unknown
- 1997-03-17 BR BR9708233-3A patent/BR9708233A/pt unknown
- 1997-03-17 EP EP97914876A patent/EP0888329A1/en not_active Ceased
- 1997-03-17 CN CN97194596A patent/CN1218463A/zh active Pending
- 1997-03-17 EE EE9800299A patent/EE9800299A/xx unknown
- 1997-03-17 SK SK1273-98A patent/SK127398A3/sk unknown
- 1997-03-17 CZ CZ982950A patent/CZ295098A3/cs unknown
- 1997-03-17 SI SI9720023A patent/SI9720023A/sl unknown
- 1997-03-17 KR KR1019980707470A patent/KR20000064735A/ko not_active Application Discontinuation
- 1997-03-17 EA EA199800844A patent/EA001207B1/ru not_active IP Right Cessation
- 1997-03-18 ZA ZA972342A patent/ZA972342B/xx unknown
- 1997-03-21 AR ARP970101148A patent/AR006521A1/es unknown
- 1997-03-21 US US08/822,996 patent/US5932749A/en not_active Expired - Fee Related
- 1997-03-21 HR HR60/013,955A patent/HRP970165A2/xx not_active Application Discontinuation
-
1998
- 1998-09-18 NO NO984344A patent/NO984344D0/no unknown
- 1998-09-18 LT LT98-132A patent/LT4540B/lt not_active IP Right Cessation
- 1998-09-21 LV LVP-98-185A patent/LV12259B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2196897A (en) | 1997-10-10 |
KR20000064735A (ko) | 2000-11-06 |
SI9720023A (sl) | 1999-04-30 |
AU719633B2 (en) | 2000-05-11 |
CA2249401A1 (en) | 1997-09-25 |
NZ331875A (en) | 2000-01-28 |
SK127398A3 (en) | 1999-04-13 |
HRP970165A2 (en) | 1998-04-30 |
LT98132A (en) | 1999-03-25 |
PL329070A1 (en) | 1999-03-15 |
BR9708233A (pt) | 2000-01-04 |
LV12259A (lv) | 1999-04-20 |
CN1218463A (zh) | 1999-06-02 |
EA199800844A1 (ru) | 1999-02-25 |
WO1997034887A1 (en) | 1997-09-25 |
US5932749A (en) | 1999-08-03 |
CZ295098A3 (cs) | 1999-03-17 |
IL126223A0 (en) | 1999-05-09 |
EA001207B1 (ru) | 2000-12-25 |
ZA972342B (en) | 1998-09-18 |
AR006521A1 (es) | 1999-09-08 |
EP0888329A1 (en) | 1999-01-07 |
JP2000506891A (ja) | 2000-06-06 |
NO984344D0 (no) | 1998-09-18 |
EE9800299A (et) | 1999-06-15 |
LT4540B (lt) | 1999-08-25 |
LV12259B (en) | 1999-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO984344L (no) | Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger | |
EE9900259A (et) | Ühendi uus vorm | |
IL126610A0 (en) | N-(amidinophenyl)-n'-(subst.)-3h-2,4-benzodiazepin-3- one derivatives as factor xa inhibitors | |
ATE228111T1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
NO996327D0 (no) | Forbedret kaskade kjoeleprosess for kondensering av naturgass | |
DK199901821A (da) | Forbedret multikomponentkøleproces til fortætning af naturgas | |
BR0215405A (pt) | Composições e processos de uso de collajolie | |
FI960889A0 (fi) | Naftyyliyhdisteitä, välituotteita, koostumuksia ja menetelmiä | |
NO20023189D0 (no) | Fremgangsmåte for fremstilling av tolterodin og analoger derav samt intermediater fremstilt ved fremgangsmåten | |
DK0912537T3 (da) | Fremgangsmåde til fremstilling af phenylheterocykliske forbindelser, der er anvendelige som cox-2-inhibitorer | |
TR200100426T2 (tr) | Nematisit pirazoller | |
DK1279665T3 (da) | Fremgangsmåde til fremstilling af perindopril, analoge forbindelser og salte heraf ved anvendelse af 2,5-dioxo-oxazolidin-mellemforbindelser | |
BR9809111A (pt) | Novos intermediários e processo para sua preparação | |
DK0981525T3 (da) | (2-(2-Thienyl)-ethylamino)-(2-halophenyl)-acetonitriler som mellemprodukter og fremgangsmåde til deres fremstilling | |
DE50111331D1 (de) | Neue verwendung von proteinhydrolysaten | |
NO20016151L (no) | Fremstilling av substituerte piperidin-4-oner | |
DE60235365D1 (de) | Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung | |
IT1317722B1 (it) | Procedimento per la produzione di gas di sintesi. | |
MXPA03008248A (es) | Agentes colorantes para fibras de queratina que contienen derivados de n-heteroarilmetil-m-fenilendiamina, asi como nuevos derivados de n-heteroarilmetil-m-fenilendiamina. | |
MXPA03002493A (es) | Proceso eficiente para preparacion de un inhibidor del factor xa. | |
DK0915858T3 (da) | Mellemprodukter til fremstilling af 2-imidazolin-5-oner | |
DK0975601T3 (da) | Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor | |
DK1023292T3 (da) | Fremgangsmåde til syntese af chlorpurinintermediater | |
DK0915076T3 (da) | Fremgangsmåde til fremstilling af trans-(R,R)-actinol | |
NO20006205D0 (no) | Morfin-6-glukuronidsyntese |